Bevacizumab/triamcinoloneEndophthalmitis: 14 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1960卷 / 1期

关键词：

D O I：

10.1007/s40278-023-40933-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：105 / 105

相关论文

共 50 条

[41] Bevacizumab/pazopanibVarious toxicities: 7 case reports
Reactions Weekly, 2013, 1461 (1) : 11 - 11
[42] Bevacizumab/fasudilNo response: 10 case reports
Reactions Weekly, 2024, 2022 (1) : 64 - 64
[43] Bevacizumab/paclitaxelVarious toxicities: 8 case reports
Reactions Weekly, 2012, 1423 (1) : 13 - 13
[44] Bevacizumab/irinotecanVarious toxicities: 4 case reports
Reactions Weekly, 2014, 1532 (1) : 54 - 54
[45] Bevacizumab/cyclophosphamide/sorafenibPneumothorax: 5 case reports
Reactions Weekly, 2017, 1653 (1) : 71 - 71
[46] Bevacizumab/perflutrenAcute endophthalmitis: 3 case reports
Reactions Weekly, 2014, 1521 (1) : 45 - 45
[47] Bevacizumab/temozolomideLack of efficacy: 4 case reports
Reactions Weekly, 2023, 1940 (1) : 114 - 114
[48] Bevacizumab/nicorandilVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1729 (1) : 52 - 52
[49] Bevacizumab/capecitabineVarious toxicities: 3 case reports
Reactions Weekly, 2014, 1524 (1) : 56 - 56
[50] Bevacizumab/irinotecanVarious toxicities: 4 case reports
Reactions Weekly, 2016, 1612 (1) : 36 - 36

← 1 2 3 4 5 →